Search
Up to one-third of young people live with chronic physical conditions (eg, diabetes, asthma, and autoimmune disease) that frequently involve recurrent pain, fatigue, activity limitations, stigma, and isolation.
Mental ill-health and substance use bear significant public health burden on young people. Prevention is key. Trauma-informed approaches to prevention of mental ill-health and substance use demonstrate significant promise, yet it is unclear how well existing approaches work for young people targeting mental ill-health and substance use. This review aimed to assess the effectiveness, feasibility, and acceptability of trauma-informed mental ill-health and/or substance use prevention programs for young people.
Alcohol use and depression are known correlates of one another, especially in men, and are influenced by a range of demographic and psychosocial factors. This study examined the association between alcohol use and depressive symptoms in a large representative cohort of Australian men. We also tested whether this association differed by men's age, household income, social support, illicit drug use and help-seeking.
The objective of this study was to examine the relationship between dietary patterns and ADHD in a population-based cohort of adolescents.
Modern societies are challenged by "wicked problems" - by definition, those that are difficult to define, multi-casual and hard to treat.
The maternal experience of stressful events during pregnancy has been associated with a number of adverse consequences for behavioral development offspring...
The aim of this study was to examine the effectiveness of Enhanced Cognitive Behaviour Therapy (CBT-E) for eating disorders in an open trial for adults...
To investigate the burden of excess mortality among people with mental illness in developed countries, how it is distributed, and whether it has changed over...
To examine the association of fetal alcohol exposure during pregnancy with child and adolescent behavioural development.
In utero exposure to antidepressant medication and neonatal growth outcomes: closer examination of the evidence is needed